|The Plet-1 n/a (Catalog #MBS570273) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The Rat anti Plet-1 reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s Plet-1 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC) (frozen), Western Blot (WB).
33A10 is useful for Flow Cytometry, Immunofluorescence, Immunohistochemistry (frozen). Optimal antibody dilution should be determined by titRation. Researchers should empirically determine the suitability of the Plet-1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The 33A10-defined antigen is the orphan protein, Placenta expressed transcript (Plet)-1. Biochemical data indiCated that Plet-1 is a glycosylphosphatidylinositol-anchored glycoprotein with N-linked carbohydRates in addition to other posttranslational modifiCations. Plet-1 is an a recently identified protein that as of yet has no known function and is not associated with any one family of proteins. Plet-1 is used as a cell surface marker present on stem/progenitor epithelial cells and in a number of tissues including thymus and skin, and on epithelial cell types in mammary gland, prostate, and pancreas.
Source Note: 33A10 is a Rat IgG2b monoclonal antibody derived by fusion of SP2/0 Mouse myeloma cells with spleen cells of Sprague-Dawley Rats immunized with Mouse mammary tumor cells. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Plet-1 are readily searchable from our website. Different antibodies against the same target such as Plet-1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.